Opinion

Lack of access to old antibiotics drives antibiotic resistance development and impairs patient outcomes

Old, but still effective antibiotics used to treat a variety of common bacterial infections are becoming more difficult to access in many countries – often because companies withdraw the drugs from the market for commercial reasons.

News

Free online course: Antibiotic Resistance: the Silent Tsunami

The free online course “Antibiotic Resistance: the Silent Tsunami” introduces the concepts of antibiotic resistance and what actions are needed to meet this global health threat. Sign up now, start 24 April.

Opinion

New antibiotics in the news

Every now and then, news headlines report on findings of new antibiotics, such as “Maple Syrup Can Kill Superbugs”. Often they are portrayed as ”new”, ”potent”, ”killing superbugs” or having ”no resistance development”. Just reading the headlines, you would be forgiven for thinking the antibiotic crisis is close to being solved. But this is not the case.

News

Tell Our Bac-Stories!

In one way or another we are all storytellers, we all have something to say. This is why ReAct Latin America, in cooperation with the University of Azuay and the Catholic University of Cuenca, has launched a regional open call: Tell Our Bac-Stories! The purpose is to collect stories about antibiotic resistance, Sumak Kawsay (an indigenous term for well being), antibiotic misuse, nutrition, mother earth, one health and similar topics.

News

Presentation of the Alforja Validation Project

A few weeks ago, the Alforja Validation Project was presented to the students of the Medicin Faculty from the Universidad Del Azuay and the Universidad Católica de Cuenca. This event took place in the Administration Room of the Universidad del Azuay, which was entirely filled with lots of enthusiastic guests.

News

Professor Otto Cars to serve as Expert in UN Inter-Agency Coordination Group on Antimicrobial Resistance

This week Professor Otto Cars, founder of ReAct – Action on Antibiotic Resistance, was formally nominated to the United Nations (UN) ad-hoc Interagency Coordination Group on Antimicrobial Resistance (ICG-AMR) by the United Nations Secretary General.

Opinion

India’s link between tuberculosis and antibiotic resistance

Improving detection, diagnosis, and treatment of tuberculosis in India, home to the world’s largest number of tuberculosis patients, may hold the key to bringing down both antimicrobial and antibiotic resistance globally.

News

India’s new National Action Plan on Antimicrobial Resistance

As one of the countries most affected by antimicrobial resistance India is now taking rapid strides to address the growing problem.

Opinion

Professor Larsson on emissions from antibiotics production and India’s National Action Plan on AMR

Professor Joakim Larsson welcomes the section focusing on emissions from antibiotics production in new India’s draft for National Action Plan on Antibiotic Resistance.

Opinion

Environmental effects of antibiotics in sewage

Clean, fresh water is one of the most important natural resources of the world. Yet large amounts of chemicals, including antibiotics, are released into the environment through wastewater.

Opinion

Boston Consulting Group report shies away from addressing affordable access and stewardship

In a follow-up to a previous report, the Boston Consulting Group (BCG) last week released Breaking through the Wall: A Call for Concerted Action on Antibiotics Research and Development, for the German Federal Ministry of Health.

Opinion

WHO Releases Priority Pathogens List

ReAct welcomes the published WHO priority pathogens list (PPL), which is the first global effort to guide and promote research and development (R&D) of new antibiotics.  The major objective of the PPL is to guide the prioritization of incentives and funding, help align R&D priorities with public health needs and support global coordination in the fight against antibiotic-resistant bacteria.

Opinion

Could the use of Antimicrobial Peptides create resistance to ourselves?

In the wake of antimicrobial resistance and the severe lack of new antibiotics being discovered, researchers have turned to alternative strategies.

News

Antibiotic Smart Use project nominated for global UN Award

In a major recognition of its contributions to public health Thailand’s Antibiotic Smart Use (ASU) project has been nominated for the prestigious UN Public Service Award 2017.

News

Recap of WHO 140th Executive Board meeting

The discussions on antimicrobial resistance (AMR) at the World Health Organization’s (WHO’s) 140th Executive Board meeting, had several interesting interventions from Member States on the key areas that the WHO was given responsibility over in the UNGA Political Declaration on AMR from September 2016.

News

New collaboration on strategies for tackling antibiotic resistance

ReAct and Stockholm Resilience Centre join forces on the global antibiotic resistance challenge.

Opinion

ReAct briefings for the 140th WHO Executive Board

For the 140th session of WHO Executive Board, which run from January 23 to February 1, ReAct has developed and shared a briefing document for the agenda point on Antimicrobial Resistance (AMR ) and a number of other relevant agenda points for Member State Missions in Geneva to consider.

News

The role of faith-based organizations in taking action against antibiotic resistance

Late December 2016 a group of more than 30 experts from the faith based health sector was invited to attend a workshop on strengthening faith-based engagement in “Combating the Emergence and Spread of Antimicrobial Resistance”, at the Vatican.

Opinion

Bacteriophages as a part of hospital hygiene

Health-care associated infections are troublesome from many aspects, not only are they often more virulent or more resistant but also strike at the heart of health care: people go to the hospital to be cured, only to contract another potentially lethal disease.

Opinion

ReAct wishes for 2017!

ReAct wishes for 2017, node by node.

Opinion

Consensus around delinkage emerges - of sorts

A literature review on proposed incentive mechanisms for the R&D of new antibiotics by the EU-US TATFAR has shown a broad consensus on recommending delinkage. However, differences in definition are hiding underneath the consensus.

Opinion

Bottlenecks of antibiotic research need to be addressed

While problems with antibiotic discovery and development are often discussed in the context of funding and return on investment, these factors are not the only ones. Even if the financial bottlenecks would be resolved, significant scientific and structural problems are still present and need to be addressed. We highlight a few of the scientific bottlenecks in antibiotic discovery, with links to further reading.